Mirae Asset Global Investments
ALT icon

Mirae Asset Global Investments’s Altimmune ALT Stock Holding History

Mirae Asset Global Investments’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4K Buy
8,698
+2,166
+33% +$6.47K ﹤0.01% 1459
2026
Q1 		$20.1K Buy
6,532
+1,462
+29% +$6.21K ﹤0.01% 1432
2025
Q4 		$18.3K Buy
5,070
+1,658
+49% +$7.23K ﹤0.01% 1549
2025
Q3 		$12.9K Buy
3,412
+279
+9% +$1.08K ﹤0.01% 1543
2025
Q2 		$12.1K Buy
3,133
+556
+22% +$3.01K ﹤0.01% 1464
2025
Q1 		$13.7K Buy
2,577
+207
+9% +$1.31K ﹤0.01% 1435
2024
Q4 		$18.2K Buy
+2,370
New +$18.1K ﹤0.01% 1433
2024
Q2 		– Sell
-26,666
Closed -$271K – 1565
2024
Q1 		$271K Buy
+26,666
New +$271K ﹤0.01% 2150
2023
Q4 		– Sell
-28,352
Closed -$73.7K – 2526
2023
Q3 		$73.7K Buy
28,352
+124
+0.4% +$356 ﹤0.01% 2517
2023
Q2 		$99.6K Buy
28,228
+7,437
+36% +$33.4K ﹤0.01% 2511
2023
Q1 		$87.7K Buy
+20,791
New +$247K ﹤0.01% 2464

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global Investments's ALT Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Altimmune (ALT) stake by 33% in Q2 2026, buying an estimated $6.47K and bringing the position to 8,698 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1459.

Mirae Asset Global Investments first reported a position in ALT in Q1 2023 and has held it in 11 quarters since. The position peaked at $271K in Q1 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Mirae Asset Global Investments held 8,698 shares of Altimmune worth $26.4K as of Q2 2026.
  • Mirae Asset Global Investments bought 2,166 Altimmune shares in Q2 2026, an estimated $6.47K.
  • Altimmune made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1459 holding.
  • Mirae Asset Global Investments first reported a position in Altimmune in Q1 2023 and has held it in 11 quarters since.
  • Mirae Asset Global Investments's Altimmune position peaked at $271K in Q1 2024.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.